These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16600446)

  • 41. Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.
    Ferry BL; Misbah SA; Stephens P; Sherrell Z; Lythgoe H; Bateman E; Banner C; Jones J; Groome N; Chapel HM
    Clin Exp Immunol; 2004 May; 136(2):297-303. PubMed ID: 15086394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate.
    Griffin TJ; Thanawastien A; Cartee RT; Mekalanos JJ; Killeen KP
    Hum Vaccin Immunother; 2019; 15(6):1310-1316. PubMed ID: 31021700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
    Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
    Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM
    Micoli F; Bjarnarson SP; Arcuri M; Aradottir Pind AA; Magnusdottir GJ; Necchi F; Di Benedetto R; Carducci M; Schiavo F; Giannelli C; Pisoni I; Martin LB; Del Giudice G; MacLennan CA; Rappuoli R; Jonsdottir I; Saul A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24443-24449. PubMed ID: 32900928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity induced by live attenuated Salmonella vaccines.
    Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
    Res Microbiol; 1990; 141(7-8):757-64. PubMed ID: 2101466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children.
    Szu SC; Klugman KP; Hunt S
    Vaccine; 2014 Apr; 32(20):2359-63. PubMed ID: 24630869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of Salmonella enterica serovar Enteritidis virulence protein, InvH, and cross-reactivity of its antisera with Salmonella strains.
    Dehghani B; Rasooli I; Gargari SL; Nadooshan MR; Owlia P; Nazarian S
    Microbiol Res; 2013 Feb; 168(2):84-90. PubMed ID: 23141708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model.
    Harrison JA; Villarreal-Ramos B; Mastroeni P; Demarco de Hormaeche R; Hormaeche CE
    Immunology; 1997 Apr; 90(4):618-25. PubMed ID: 9176117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Polysaccharide isolated from the liquid culture of Lentinus edodes (Shiitake) mushroom mycelia containing black rice bran protects mice against salmonellosis through upregulation of the Th1 immune reaction.
    Kim SP; Park SO; Lee SJ; Nam SH; Friedman M
    J Agric Food Chem; 2014 Mar; 62(11):2384-91. PubMed ID: 24593132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
    Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
    J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines.
    Sydenham M; Douce G; Bowe F; Ahmed S; Chatfield S; Dougan G
    Infect Immun; 2000 Mar; 68(3):1109-15. PubMed ID: 10678914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mice vaccinated with a non-virulent, aromatic-dependent mutant of Salmonella choleraesuis die from challenge with its virulent parent but survive challenge with Salmonella typhimurium.
    Nnalue NA
    J Med Microbiol; 1990 Apr; 31(4):225-33. PubMed ID: 2139129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice.
    Coynault C; Norel F
    Microb Pathog; 1999 Jun; 26(6):299-305. PubMed ID: 10343058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salmonella DNA adenine methylase mutants elicit early and late onset protective immune responses in calves.
    Dueger EL; House JK; Heithoff DM; Mahan MJ
    Vaccine; 2003 Jul; 21(23):3249-58. PubMed ID: 12804855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
    Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
    J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.
    An SJ; Yoon YK; Kothari S; Kim DR; Kim JA; Kothari N; Lee E; Park TH; Carbis R
    Vaccine; 2012 Feb; 30(6):1023-8. PubMed ID: 22192846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insertion of a 59 amino acid peptide in Salmonella Typhimurium membrane results in loss of virulence in mice.
    Porta A; Morello S; Granata I; Iannone R; Maresca B
    FEBS J; 2014 Nov; 281(22):5043-53. PubMed ID: 25208333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
    Fattom AI; Sarwar J; Ortiz A; Naso R
    Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.